ChemomAb Ltd. Report issue

For profit Phase 1 Phase 2
Founded: Tel Aviv Israel (2011)

Organization Overview

First Clinical Trial
2020
NCT04595825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ChemomAb Ltd.